ミオグロビン市場：タイプ、検出方法、エンドユーザー別-2025～2030年の世界予測

ミオグロビン市場は、2023年に9,741万米ドルと評価され、2024年には1億107万米ドルに達すると予測され、CAGR 3.91％で成長し、2030年には1億2,749万米ドルになると予測されています。

ミオグロビンはヘム含有タンパク質で、主に筋肉組織における酸素の運搬と貯蔵の役割が認められています。特に筋損傷や心筋梗塞のような状態の早期発見が可能であることから、医療診断や調査において極めて重要です。ミオグロビンの必要性は、その感度の高さと筋損傷後の血流への迅速な放出に起因しており、タイムリーな診断のために臨床現場で非常に貴重なものとなっています。その用途は医療にとどまらず、科学研究、スポーツ選手のモニタリングのためのスポーツ医療、食肉品質評価のための食品産業などにも利用されています。最終用途の範囲には、病院、診断ラボ、研究機関、食品加工会社などが含まれます。

市場洞察によると、心血管疾患の有病率の増加と健康意識の高まりが、ミオグロビン市場の重要な成長促進要因であることが明らかになっています。バイオテクノロジーにおける用途の拡大と研究開発への投資の増加が市場拡大をさらに後押ししています。特に医療インフラへの投資が増加している新興国市場では、ポイントオブケア検査ソリューションの進歩や新規診断アッセイの開発に主要ビジネス機会が存在します。しかし、代替バイオマーカーとの競合、規制上のハードル、検査費用の高騰といった課題は、市場の成長を阻害する可能性があります。また、技術的な障壁や検査結果のばらつきによる限界にも直面しており、診断精度を高めるためのアッセイ感度や特異度の革新が求められています。

技術革新が必要なセグメントには、費用対効果が高く迅速な診断装置の開発、診断における予測分析のための人工知能の統合、食品産業における食肉の品質向上のためのミオグロビン変異体の生物工学的改良などがあります。個別化医療と精密診断における調査の進展は、さらなる成長の道を示しています。市場の性質はダイナミックであり、技術の進歩に牽引され、イノベーションは競争優位性を維持するために極めて重要です。利害関係者は、課題を効果的に克服し、新たな機会を活用するために、強固な研究協力に投資し、アプリケーション・ポートフォリオを多様化することが推奨されます。

市場力学：急速に進化するミオグロビン市場の主要市場洞察を公開

ミオグロビン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業組織は十分な情報に基づいた投資決定、戦略的決定の精緻化、新たなビジネス機会の獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患患者の増加と効果的な診断・治療ソリューションの必要性
  • バイオテクノロジー研究への投資とパートナーシップの拡大
• 市場抑制要因
  • ミオグロビンに関連する厳しい規制要件
• 市場機会
  • 臨床検査やラボでの大幅な採用
  • 食肉産業における色パラメータ制御のための新たな使用法
• 市場課題
  • ミオグロビンの抽出に伴う複雑さ

ポーターのファイブフォース：ミオグロビン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、ミオグロビン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ミオグロビン市場における外部からの影響の把握

外部マクロ環境要因は、ミオグロビン市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：ミオグロビン市場における競合情勢の把握

ミオグロビン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：ミオグロビン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ミオグロビン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：ミオグロビン市場における成功への道筋を描く

ミオグロビン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の増加と効果的な診断と治療ソリューションの必要性
    • バイオテクノロジー調査への投資と提携の拡大
  • 抑制要因
    • ミオグロビンに関連する厳格な規制要件
  • 機会
    • 臨床検査やラボでの大幅な導入
    • 肉産業で色パラメータを制御するための新たな用途
  • 課題
    • ミオグロビンの抽出に伴う複雑さ
• 市場セグメンテーション分析
  • タイプ：患者のアンメットニーズに応えるための研究とイノベーションにおける動物ベースのミオグロビンの活用
  • エンドユーザー：筋肉関連の損傷を特定するための診断ラボでのミオグロビンの使用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 ミオグロビン市場：タイプ別

• イントロダクション
• 動物
• 人間

第7章 ミオグロビン市場：検出方法別

• イントロダクション
• 酵素免疫測定法
• 免疫組織化学
• 質量分析
• ウエスタンブロッティング

第8章 ミオグロビン市場：エンドユーザー別

• イントロダクション
• 診断ラボ
• 病院・クリニック
• 製薬・バイオテクノロジー企業
• 研究機関

第9章 南北アメリカのミオグロビン市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のミオグロビン市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのミオグロビン市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • CytoSorbentsが中国でCytoSorbを販売するためのTFDA承認を取得
  • ベルギーのスタートアップ企業Paleoは精密発酵技術を活用して酵母ベースのミオグロビンを生産
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• BBI Solutions
• Bio Rad Laboratories Inc.
• Bio SB, Inc.
• bioMerieux S.A.
• Boditech Med Inc.
• DiaSorin S.p.A
• DiaSys Diagnostic Systems GmbH
• F. Hoffmann-La Roche AG
• GenScript
• Horiba, Ltd.
• Leica Biosystems Nussloch GmbH
• Merck KGaA
• OriGene Technologies, Inc.
• PerkinElmer Inc.
• Randox Laboratories Ltd.
• Scripps Laboratories Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Tosoh Corporation

LIST OF FIGURES

• FIGURE 1. MYOGLOBIN MARKET RESEARCH PROCESS
• FIGURE 2. MYOGLOBIN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MYOGLOBIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MYOGLOBIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MYOGLOBIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MYOGLOBIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MYOGLOBIN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MYOGLOBIN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES MYOGLOBIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES MYOGLOBIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. MYOGLOBIN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. MYOGLOBIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MYOGLOBIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MYOGLOBIN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MYOGLOBIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MYOGLOBIN MARKET DYNAMICS
• TABLE 7. GLOBAL MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MYOGLOBIN MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MYOGLOBIN MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MYOGLOBIN MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MYOGLOBIN MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MYOGLOBIN MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MYOGLOBIN MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MYOGLOBIN MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MYOGLOBIN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MYOGLOBIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MYOGLOBIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 32. CANADA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES MYOGLOBIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 49. CHINA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 52. INDIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 104. ITALY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 116. POLAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 119. QATAR MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. MYOGLOBIN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. MYOGLOBIN MARKET, FPNV POSITIONING MATRIX, 2023

The Myoglobin Market was valued at USD 97.41 million in 2023, expected to reach USD 101.07 million in 2024, and is projected to grow at a CAGR of 3.91%, to USD 127.49 million by 2030.

Myoglobin is a heme-containing protein primarily recognized for its role in transporting and storing oxygen in muscle tissues. It is pivotal in medical diagnostics and research, particularly for its early detection capabilities of muscle injury and conditions such as myocardial infarction. The necessity of myoglobin stems from its high sensitivity and rapid release into the bloodstream following muscle damage, making it invaluable in clinical settings for timely diagnosis. Its applications extend beyond healthcare, being utilized in scientific research, sports medicine for monitoring athletes, and the food industry for meat quality assessment. The end-use scope includes hospitals, diagnostic laboratories, research institutes, and food processing companies.

Market insights reveal that the growing prevalence of cardiovascular diseases and increasing health awareness are significant growth drivers for the myoglobin market. The expanding applications in biotechnology and increasing investments in research and development further fuel market expansion. Key opportunities exist in advancing point-of-care testing solutions and developing novel diagnostic assays, especially in emerging markets with rising healthcare infrastructure investments. However, challenges such as competition from alternative biomarkers, regulatory hurdles, and high costs of testing can impede market growth. The market also faces limitations from technological barriers and variability in test results, which demand innovations in assay sensitivity and specificity to enhance diagnostic accuracy.

Areas ripe for innovation include developing cost-effective and faster diagnostic devices, integrating artificial intelligence for predictive analytics in diagnostics, and enhancing the bioengineering of myoglobin variants for improved meat quality in the food industry. Research advancements in personalized medicine and precision diagnostics present further growth avenues. The market's nature is dynamic, driven by technological advancements, with innovation being crucial for maintaining competitive advantage. Stakeholders are recommended to invest in robust research collaborations and diversify application portfolios to navigate challenges effectively and leverage emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Myoglobin Market

The Myoglobin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing cases of cardiovascular diseases and the need for effective diagnostic and therapeutic solutions
  • Growing investments and partnerships in biotechnological research
• Market Restraints
  • Strict regulatory requirements associated with the myoglobin
• Market Opportunities
  • Significant adoption in clinical trials and research laboratories
  • Emerging usage in meat industries to control color parameter
• Market Challenges
  • Complexities associated with the extraction of myoglobin

Porter's Five Forces: A Strategic Tool for Navigating the Myoglobin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Myoglobin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Myoglobin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Myoglobin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Myoglobin Market

A detailed market share analysis in the Myoglobin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Myoglobin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Myoglobin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Myoglobin Market

A strategic analysis of the Myoglobin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Myoglobin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BBI Solutions, Bio Rad Laboratories Inc., Bio SB, Inc., bioMerieux S.A., Boditech Med Inc., DiaSorin S.p.A, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche AG, GenScript, Horiba, Ltd., Leica Biosystems Nussloch GmbH, Merck KGaA, OriGene Technologies, Inc., PerkinElmer Inc., Randox Laboratories Ltd., Scripps Laboratories Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Myoglobin Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Animal and Human.
• Based on Detection Method, market is studied across Enzyme-Linked Immunosorbent Assay, Immunohistochemistry, Mass Spectrometry, and Western Blotting.
• Based on End-User, market is studied across Diagnostic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of cardiovascular diseases and the need for effective diagnostic and therapeutic solutions
    • 5.1.1.2. Growing investments and partnerships in biotechnological research
  • 5.1.2. Restraints
    • 5.1.2.1. Strict regulatory requirements associated with the myoglobin
  • 5.1.3. Opportunities
    • 5.1.3.1. Significant adoption in clinical trials and research laboratories
    • 5.1.3.2. Emerging usage in meat industries to control color parameter
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities associated with the extraction of myoglobin
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Utilization of animal-based myoglobin in research and innovation to cater to unmet needs of patients
  • 5.2.2. End-User: Increasing usage of myoglobin in diagnostic laboratories for identification of muscle-related injuries
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Myoglobin Market, by Type

• 6.1. Introduction
• 6.2. Animal
• 6.3. Human

7. Myoglobin Market, by Detection Method

• 7.1. Introduction
• 7.2. Enzyme-Linked Immunosorbent Assay
• 7.3. Immunohistochemistry
• 7.4. Mass Spectrometry
• 7.5. Western Blotting

8. Myoglobin Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Laboratories
• 8.3. Hospitals & Clinics
• 8.4. Pharmaceutical & Biotechnology Companies
• 8.5. Research Institutes

9. Americas Myoglobin Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Myoglobin Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Myoglobin Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. CytoSorbents receives TFDA approval to distribute CytoSorb in China
  • 12.3.2. Belgian startup Paleo leverages precision fermentation to produce yeast-based myoglobin
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. BBI Solutions
• 3. Bio Rad Laboratories Inc.
• 4. Bio SB, Inc.
• 5. bioMerieux S.A.
• 6. Boditech Med Inc.
• 7. DiaSorin S.p.A
• 8. DiaSys Diagnostic Systems GmbH
• 9. F. Hoffmann-La Roche AG
• 10. GenScript
• 11. Horiba, Ltd.
• 12. Leica Biosystems Nussloch GmbH
• 13. Merck KGaA
• 14. OriGene Technologies, Inc.
• 15. PerkinElmer Inc.
• 16. Randox Laboratories Ltd.
• 17. Scripps Laboratories Inc.
• 18. Siemens Healthineers AG
• 19. Thermo Fisher Scientific Inc.
• 20. Tosoh Corporation